APA (7th ed.) Citation

Gao F, Qiang H, Fan XJ, Xue Q, & Bai L. (2019). Higher serum total bilirubin predicts high risk of 3-year adverse outcomes in patients undergoing primary percutaneous coronary intervention. Dove Medical Press.

Chicago Style (17th ed.) Citation

Gao F, Qiang H, Fan XJ, Xue Q, and Bai L. Higher Serum Total Bilirubin Predicts High Risk of 3-year Adverse Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention. Dove Medical Press, 2019.

MLA (9th ed.) Citation

Gao F, et al. Higher Serum Total Bilirubin Predicts High Risk of 3-year Adverse Outcomes in Patients Undergoing Primary Percutaneous Coronary Intervention. Dove Medical Press, 2019.